Search

Quick Filters

Compliance Status
Clear

Clinical Trials Data

Showing 543025 of 543136 entries
View as:

Lacrimal Deroofing for Epiphora From Punctal Abnormalities

Phase: N/A Priority: Normal
NCT ID: NCT04898933 Org: User:
Start: 01/20/22 End: 01/23/25 Due: 01/23/26

Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Adizutecan (ABBV-400) Moves Through the Body of Adult Participants With Unresectable Locally Advanced/Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06464692 Org: User:
Start: 09/30/24 End: 09/30/28 Due: 09/30/29

DLL3-Directed Chimeric Antigen Receptor T-cells in Subjects With Extensive Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05680922 Org: User:
Start: 07/26/23 End: 03/31/28 Due: 03/31/29

Evaluation of GTPase Inhibition by Post-operative Intravenous Ketorolac in Ovarian Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT02470299 Org: User:
Start: 10/29/15 End: 01/25/24 Due: 01/25/25

A Study of GFH009 in Combination with Zanubrutinib in Subjects with Relapsed or Refractory DLBCL

Phase: N/A Priority: Normal
NCT ID: NCT06375733 Org: User:
Start: 03/20/24 End: 12/31/26 Due: 12/31/27

Effect of Healthy Lunch and Snack Meal on Reaction Time and Well-being of Physicians and Nursing Staff (Go-No-Go)

Phase: N/A Priority: Normal
NCT ID: NCT01739569 Org: User:
Start: 08/31/12 End: 12/31/12 Due: 12/31/13

Nivolumab Plus Lenvatinib Against Anaplastic Thyroid Cancer (NAVIGATION)

Phase: N/A Priority: Normal
NCT ID: NCT05696548 Org: User:
Start: 07/02/19 End: 12/31/26 Due: 12/31/27

Lu-PSMA for Oligometastatic Prostate Cancer Treated With STereotactic Ablative Radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT05560659 Org: User:
Start: 12/14/23 End: 05/31/26 Due: 05/31/27

Effects of TT301 on Cytokine Levels Post Endotoxin Challenge

Phase: N/A Priority: Normal
NCT ID: NCT01357421 Org: User:
Start: 05/31/11 End: 06/30/11 Due: 06/30/12

The Effects of Covid-19 Pandemic on The Patients With Fibromyalgia

Phase: N/A Priority: Normal
NCT ID: NCT04686578 Org: User:
Start: 12/01/20 End: 02/28/21 Due: 02/28/22

Elotuzumab and Lenalidomide After Stem Cell Transplant in Treating Patients With Newly Diagnosed Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT02420860 Org: User:
Start: 04/14/15 End: 04/30/27 Due: 04/30/28

Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03071406 Org: User:
Start: 03/14/17 End: 10/31/25 Due: 10/31/26

Eatable Alphabet as a Nutrition Education Tool

Phase: N/A Priority: Normal
NCT ID: NCT05166629 Org: User:
Start: 09/01/23 End: 12/31/26 Due: 12/31/27

Improving Patient-centered Care for Diabetes in Bangladesh Through "Dynamic Integration" of Vision Care on the Demand Side

Phase: N/A Priority: Normal
NCT ID: NCT06968611 Org: User:
Start: 07/31/25 End: 12/31/26 Due: 12/31/27

Efficacy of Mouthwashes in Reducing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Saliva

Phase: N/A Priority: Normal
NCT ID: NCT04723446 Org: User:
Start: 05/19/21 End: 10/25/21 Due: 10/25/22

Investigation on the Effect of Carnitine Supplement on Gut Microbiota and TMAO Production Capacity

Phase: N/A Priority: Normal
NCT ID: NCT02838732 Org: User:
Start: 05/18/16 End: 10/07/19 Due: 10/07/20

Lung Function, Exercise Capacity and Health-Related Quality of Life After Severe COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT04410107 Org: User:
Start: 05/15/20 End: 07/30/23 Due: 07/30/24

Evaluation of a Trifocal Lens

Phase: N/A Priority: Normal
NCT ID: NCT04545671 Org: User:
Start: 11/01/20 End: 03/16/22 Due: 03/16/23

Sigma CR150 Versus Sigma CR Knee RCT

Phase: N/A Priority: Normal
NCT ID: NCT01418378 Org: User:
Start: 08/03/11 End: 02/17/16 Due: 02/17/17

Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (SCCis)

Phase: N/A Priority: Normal
NCT ID: NCT06577311 Org: User:
Start: 08/14/24 End: 08/31/25 Due: 08/31/26

Parents in Transition - a Nurse-led Support and Transfer Education Program

Phase: N/A Priority: Normal
NCT ID: NCT04969328 Org: User:
Start: 07/01/21 End: 12/31/24 Due: 12/31/25

ESP1/SARC025 Global Collaboration: A Phase I Study of a Combination of the PARP Inhibitor, Niraparib and Temozolomide and/or Irinotecan Patients With Previously Treated, Incurable Ewing Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT02044120 Org: User:
Start: 05/31/14 End: 01/31/21 Due: 01/31/22

Pain After Tonsillectomy Study

Phase: N/A Priority: Normal
NCT ID: NCT03538730 Org: User:
Start: 01/12/18 End: 06/30/19 Due: 06/30/20

European Active Surveillance Study (EURAS)

Phase: N/A Priority: Normal
NCT ID: NCT00302848 Org: User:
Start: 11/30/00 End: 12/31/05 Due: 12/31/06

Is Breast Massage Necessary to Find Sentinel Lymph Node?

Phase: N/A Priority: Normal
NCT ID: NCT05663112 Org: User:
Start: 12/06/21 End: 07/06/23 Due: 07/06/24